"The Russian Direct Investment Fund (RDIF, the sovereign wealth fund of the Russian Federation) and the Torlak Institute of Virology, Vaccines and Serums announce the launch of production of the Russian Sputnik V coronavirus vaccine in Serbia," the fund said.
It is noted that Serbia “became the first state in Southern Europe to produce Sputnik V”.
“Production in Serbia meets the strictest standards,” added the RDIF.
Earlier, the head of RDIF, Kirill Dmitriev, spoke about plans to produce the Russian Sputnik V coronavirus vaccine.